Scilex Pharmaceuticals Tour HD Master

(1:55)

Behind the Bell: Scilex Holding Company

(1:24)

Scilex Pharmaceuticals Tour HD Master

(1:55)

Scilex Holding Company, a majority owned subsidiary of Sorrento Therapeutics, Inc , Debuts on Nasdaq

(11:53)

SCLX Stock: SCILEX Stock is one to watch!

(4:9)

Cramer: This biotech stock could be worth over $100 billion on an FDA approval

(5:19)

Sorrento subsidiary Scilex to go public via SPAC deal with Vickers Vantage

(58)

Fireside Chat with Cingulate's CEO Shane Schaffer

(8:19)

Focus on supply chain and manufacturing in expansion plans: Telix Pharma CEO

(2:44)

A DAY IN THE LIFE OF A MEDICAL SALES REP | Breaking into the Industry, Sales Tips, Traveling Alone

(12:54)

Where to get Semaglutide and Tirzepatide if you don't do Compounding? | Member Feedback

(8:15)

2024 CEO Chat: Conley Chee, CEO of Syros Pharmaceuticals

(6:5)

ISHLTv Professional Community Webinar - Pharmacy (19 November, 2024)

(1:9:4)

ESMO 2024 - Sven Schaffer

(9:39)

The lowdown on Pharmacy - salary, saturation, career pathways

(21:2)

Innovative Pharmaceutical Supply Chains at Novartis

(1:4:5)

Markets are in a tailspin, where is the bottom? a pharma champion doing well in this carnage?

(10:59)

New Treatment for Post-Herpetic Neuralgia in Adults | ZTLIDO® (lidocaine topical system)

(1:34)

5 Top Biotech Stocks to Watch in 2024

(6:30)

The CEO of $SLRX Stock - Salarius Pharmaceuticals On Epigenetics, Strategy, Speed and Expansion!

(39:44)

How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks

(13:29)

This Stock Is About To SQUEEZE!?🔥*URGENT*

(11:27)

Creating Pharmaceuticals to Improve Neurological Function

(25:6)

Big Pharma DEMOCRAT Shills For Drug Companies

(9:46)

Esperion Therapeutics (ESPR) CEO on Cholesterol Lowering Medications

(5:52)

This crisis will stop now

(45)

Here's where investors can find opportunity in pharma

(3:52)

Dr. Scott Gottlieb on obesity drug costs: Expect to see continued price reductions

(6:57)